IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
32.83
-1.22 (-3.58%)
Mar 12, 2026, 4:00 PM EDT - Market closed
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of $2.88 billion as of March 13, 2026. Its market cap has increased by 58.72% in one year.
Market Cap
2.88B
Enterprise Value
1.86B
1-Year Change
58.72%
Ranking
Category
Stock Price
$32.83
Market Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from $215.57M to $2.88B, an increase of 1,237.37%. That is a compound annual growth rate of 46.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 2.88B | -4.87% |
| Dec 31, 2025 | 3.03B | 36.44% |
| Dec 31, 2024 | 2.22B | -3.15% |
| Dec 29, 2023 | 2.29B | 162.34% |
| Dec 30, 2022 | 874.22M | -3.92% |
| Dec 31, 2021 | 909.90M | 123.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edgewise Therapeutics | 3.21B |
| Spyre Therapeutics | 3.17B |
| Alumis | 3.12B |
| Dyne Therapeutics | 2.98B |
| Vera Therapeutics | 2.94B |
| Viridian Therapeutics | 2.90B |
| Tarsus Pharmaceuticals | 2.90B |
| Catalyst Pharmaceuticals | 2.86B |